COVID-19 vaccine

Moderna has begun a Phase 1 clinical trial of an Ebola vaccine targeting the Zaire strain responsible for the outbreak in the Democratic Republic of the Congo. The trial marks the first human testing of the candidate, which uses the same mRNA technology behind Moderna's COVID-19 vaccine. Coverage is highlighting the company's growing pipeline and the urgent need for new Ebola countermeasures in central Africa.

Reports say the US Food and Drug Administration has approved the first mRNA-based flu vaccine, marking a new application of the technology widely used in COVID-19 vaccines. The trending term reflects news headlines about the decision. Beyond the headline itself, the available posts contain no further details on the vaccine's maker, availability, or public reaction, so what people are saying beyond sharing the news is not clear from the posts.

A new survey from the National Foundation for Infectious Diseases finds that most US adults support vaccines, yet many remain unclear about current recommendations for respiratory vaccines, such as those for flu, COVID-19, and RSV. The findings highlight a gap between general trust in vaccination and public understanding of which shots are advised and when.

The updated 2026-2027 COVID-19 vaccine has become available, and people are booking appointments at pharmacies such as Walgreens, including Moderna boosters. The rollout comes as US trackers report a 13th COVID wave, with outbreaks in 40 states and territories and millions of estimated current infections, prompting renewed calls for annual boosters.

The Cattaraugus County Health Department in western New York will begin running influenza and Covid-19 vaccination clinics for residents. The announcement signals the start of the respiratory illness season vaccination push, giving residents local access to both seasonal flu shots and updated Covid vaccines as health officials prepare for fall and winter illness.